What are the major opportunities in the Asthma Therapeutics market? What are the strategies for the Asthma Therapeutics market?

For detailed insights on the major opportunities and strategies in the Asthma Therapeutics market, Read More

How does the Asthma Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Asthma Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Asthma Therapeutics market growth? SWOT analysis of the Asthma Therapeutics market.

For detailed insights on the key dynamics influencing the Asthma Therapeutics market growth and SWOT analysis of the Asthma Therapeutics industry, Read More

Asthma Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Asthma Therapeutics Market Report 2026

Name: Asthma Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)), By Treatment Stage (Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications), By Route Of administration (Oral, Inhaled, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Homecare, Specialty Clinics) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Asthma Therapeutics Market Overview

• Asthma Therapeutics market size has reached to $33.11 billion in 2025

• Expected to grow to $47.87 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%

• Growth Driver: Increasing Prevalence Of Asthma Fueling The Growth Of The Market Due To Rising Exposure To Air Pollution And Associated Health Risks

• Market Trend: Advancements In Anti Inflammatory Rescue Inhalers Improve Symptom Relief And Airway Inflammation Management In Asthma

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Asthma Therapeutics Market?

Asthma therapeutics refers to the range of medications and treatments used to manage and relieve asthma symptoms, a chronic respiratory condition characterized by airway inflammation and constriction. These therapies include quick-relief medications for immediate symptom control and long-term control drugs that help reduce airway inflammation and prevent asthma attacks.

The main types of drug classes included in asthma therapeutics are inhaled corticosteroids (ICS), long-acting beta agonists, leukotriene receptor antagonists, short-acting beta agonists, biologics, and combination inhalers. Inhaled corticosteroids are medicines breathed directly into the lungs to reduce inflammation and swelling in the airways, making it easier to breathe for people with asthma. They are used at different treatment stages, such as acute treatment, long-term control, preventive treatment, maintenance regimens, and rescue medications, by various routes of administration, including oral, inhaled, intravenous, and subcutaneous. They are different distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by several end-users, including hospitals, home care, and specialty clinics.

Asthma Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Asthma Therapeutics Market Size and Share 2026?

The asthma therapeutics market size has grown strongly in recent years. It will grow from $33.11 billion in 2025 to $35.73 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to limited availability of biologics, reliance on short-acting beta agonists, rising prevalence of asthma globally, increasing hospital and specialty clinic visits, adoption of oral and inhaled medications.

What Is The Asthma Therapeutics Market Growth Forecast?

The asthma therapeutics market size is expected to see strong growth in the next few years. It will grow to $47.87 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to development of novel biologics and combination therapies, expansion of telemedicine and digital health monitoring, growing preventive treatment awareness, increasing healthcare access in emerging markets, rising investment in research and drug development. Major trends in the forecast period include rising adoption of personalized asthma therapies, increase in inhaler and biologic usage, expansion of homecare and remote monitoring solutions, growing preference for combination inhalers, enhanced focus on pediatric and geriatric asthma care.

Book your 30 minutes free consultation with our research experts

Global Asthma Therapeutics Market Segmentation

1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

What Is The Driver Of The Asthma Therapeutics Market?

The increasing prevalence of asthma is expected to propel the growth of the asthma therapeutics market going forward. Asthma refers to a long-term disease that causes inflammation and swelling of the airways, resulting in the narrowing of the airways that carry air from the nose and mouth to the lungs. The increasing prevalence of asthma is due to increasing pollutants, which irritate the airways and raise the risk of developing the condition. Asthma therapeutics help manage asthma by controlling airway inflammation, relieving symptoms, and preventing asthma attacks. For instance, in May 2025, according to the UK Parliament, a UK-based government body, there were 3,886,879 people over the age of six diagnosed with asthma in 2023-24, accounting for 6.5% of England’s population. Therefore, the increasing prevalence of asthma is driving the growth of the asthma therapeutics industry.

Key Players In The Global Asthma Therapeutics Market

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V.

Global Asthma Therapeutics Market Trends and Insights

Major companies operating in the asthma therapeutics market are focusing on developing innovative solutions such as anti-inflammatory rescue inhaler to enhance symptom relief, inflammation control, and overall disease management. Anti-inflammatory rescue inhaler is a dual-action therapeutic approach that combines a fast-acting bronchodilator with an inhaled corticosteroid in a single inhaler, enabling capabilities such as rapid bronchodilation, on-demand inflammation reduction, and prevention of severe asthma attacks. For instance, in January 2024, AstraZeneca plc, a UK-based biopharmaceutical company, launched AIRSUPRA, an FDA-approved anti-inflammatory rescue inhaler designed to deliver immediate symptom relief alongside fast anti-inflammatory action, featuring as-needed dual-mechanism dosing, real-time airway inflammation suppression, and support in preventing exacerbation-related lung-function decline. AIRSUPRA improves asthma control, reduces the risk of severe attacks, and strengthens overall rescue-therapy effectiveness.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Asthma Therapeutics Market?

In January 2025, Phillips Medisize, a U.S.-based contract development and manufacturing organization (CDMO), acquired Vectura Group Ltd. for an undisclosed amount. With this acquisition, Phillips Medisize aims to enhance its inhalation drug-delivery capabilities by integrating Vectura’s deep formulation and device expertise across dry powder inhalers, nebulizers, metered-dose inhalers, and nasal systems. Vectura Group Ltd. is a U.K.–based company that specializes in inhalation formulation, device development, and regulatory-support services.

Regional Insights

North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Asthma Therapeutics Market?

The asthma therapeutics market consists of revenues earned by entities by providing services such as prescription management, inhaler technique training, nebulization therapy, and allergy testing and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The asthma therapeutics market consists of sales of methylxanthines, anticholinergics, systemic corticosteroids, mast cell stabilizers, immunotherapy products, and adjunctive therapies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Asthma Therapeutics Market Report 2026?

The asthma therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the asthma therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Asthma Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$35.73 billion
Revenue Forecast In 2035	$47.87 billion
Growth Rate	CAGR of 7.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Treatment Stage, Route Of administration, Distribution Channel, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Far
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Asthma Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Asthma Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Asthma Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Asthma Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Rising Adoption Of Personalized Asthma Therapies

4.2.2 Increase In Inhaler And Biologic Usage

4.2.3 Expansion Of Homecare And Remote Monitoring Solutions

4.2.4 Growing Preference For Combination Inhalers

4.2.5 Enhanced Focus On Pediatric And Geriatric Asthma Care

5. Asthma Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Homecare Patients

5.3 Specialty Clinics

5.4 Pharmacies

5.5 Research Institutions

6. Asthma Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Asthma Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Asthma Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Asthma Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Asthma Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Asthma Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Asthma Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Asthma Therapeutics Market Segmentation

9.1. Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

9.2. Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

9.3. Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Inhaled, Intravenous, Subcutaneous

9.4. Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics

9.6. Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

9.7. Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Salmeterol, Formoterol, Indacaterol, Olodaterol

9.8. Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Montelukast, Zafirlukast, Pranlukast

9.9. Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Albuterol (Salbutamol), Levalbuterol, Terbutaline

9.10. Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

9.11. Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

10. Asthma Therapeutics Market Regional And Country Analysis

10.1. Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Asthma Therapeutics Market

11.1. Asia-Pacific Asthma Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Asthma Therapeutics Market

12.1. China Asthma Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Asthma Therapeutics Market

13.1. India Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Asthma Therapeutics Market

14.1. Japan Asthma Therapeutics Market Overview

14.2. Japan Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Asthma Therapeutics Market

15.1. Australia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Asthma Therapeutics Market

16.1. Indonesia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Asthma Therapeutics Market

17.1. South Korea Asthma Therapeutics Market Overview

17.2. South Korea Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Asthma Therapeutics Market

18.1. Taiwan Asthma Therapeutics Market Overview

18.2. Taiwan Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Asthma Therapeutics Market

19.1. South East Asia Asthma Therapeutics Market Overview

19.2. South East Asia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Asthma Therapeutics Market

20.1. Western Europe Asthma Therapeutics Market Overview

20.2. Western Europe Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Asthma Therapeutics Market

21.1. UK Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Asthma Therapeutics Market

22.1. Germany Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Asthma Therapeutics Market

23.1. France Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Asthma Therapeutics Market

24.1. Italy Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Asthma Therapeutics Market

25.1. Spain Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Asthma Therapeutics Market

26.1. Eastern Europe Asthma Therapeutics Market Overview

26.2. Eastern Europe Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Asthma Therapeutics Market

27.1. Russia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Asthma Therapeutics Market

28.1. North America Asthma Therapeutics Market Overview

28.2. North America Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Asthma Therapeutics Market

29.1. USA Asthma Therapeutics Market Overview

29.2. USA Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Asthma Therapeutics Market

30.1. Canada Asthma Therapeutics Market Overview

30.2. Canada Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Asthma Therapeutics Market

31.1. South America Asthma Therapeutics Market Overview

31.2. South America Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Asthma Therapeutics Market

32.1. Brazil Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Asthma Therapeutics Market

33.1. Middle East Asthma Therapeutics Market Overview

33.2. Middle East Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Asthma Therapeutics Market

34.1. Africa Asthma Therapeutics Market Overview

34.2. Africa Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Asthma Therapeutics Market Regulatory and Investment Landscape

36. Asthma Therapeutics Market Competitive Landscape And Company Profiles

36.1. Asthma Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Asthma Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Asthma Therapeutics Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Asthma Therapeutics Market Other Major And Innovative Companies

Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V

38. Global Asthma Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Asthma Therapeutics Market

40. Asthma Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Asthma Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Asthma Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Asthma Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Asthma Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Asthma Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Asthma Therapeutics Market, Supply Chain Analysis

Table 4: Global Asthma Therapeutics Market, Major Raw Material Providers

Table 5: Global Asthma Therapeutics Market, Major Resource Providers

Table 6: Global Asthma Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Asthma Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Asthma Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Asthma Therapeutics Market, Major Trends

Table 10: Global Asthma Therapeutics Market, Major End Users

Table 11: Global Asthma Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Asthma Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Asthma Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Asthma Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Global Asthma Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 101: Global Asthma Therapeutics Market - Company Scoring Matrix

Table 102: Roche Holding AG Financial Performance

Table 103: Merck & Co Inc. Financial Performance

Table 104: Pfizer Inc. Financial Performance

Table 105: AstraZeneca plc Financial Performance

Table 106: Sanofi S.A. Financial Performance

Table 107: Global Asthma Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 108: Global Asthma Therapeutics Market, Competitive Dashboard

Table 109: Global Asthma Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 110: Global, Asthma Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 111: Global, Asthma Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment Stage, 2025 – 2030

Table 112: Global, Asthma Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of administration, 2025 – 2030

List Of Figures

Figure 1: Global Asthma Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Asthma Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Asthma Therapeutics Market, Supply Chain Analysis

Figure 4: Global Asthma Therapeutics Market, Major Raw Material Providers

Figure 5: Global Asthma Therapeutics Market, Major Resource Providers

Figure 6: Global Asthma Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Asthma Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Asthma Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Asthma Therapeutics Market, Major Trends

Figure 10: Global Asthma Therapeutics Market, Major End Users

Figure 11: Global Asthma Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Asthma Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Asthma Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Asthma Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Global Asthma Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 101: Global Asthma Therapeutics Market - Company Scoring Matrix

Figure 102: Roche Holding AG Financial Performance

Figure 103: Merck & Co Inc. Financial Performance

Figure 104: Pfizer Inc. Financial Performance

Figure 105: AstraZeneca plc Financial Performance

Figure 106: Sanofi S.A. Financial Performance

Figure 107: Global Asthma Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 108: Global Asthma Therapeutics Market, Competitive Dashboard

Figure 109: Global Asthma Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 110: Global, Asthma Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 111: Global, Asthma Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment Stage, 2025 – 2030

Figure 112: Global, Asthma Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Asthma Spacers Market Report 2026 - Global Outlook – By Product (Aerochamber, Optichamber, Volumatic, Inspirease, Other Products), By Distribution Channels (E-commerce Channels, Retail Pharmacies, Hospital Pharmacies, Ot...

Allergic Rhinitis Drugs Market Report 2026 - Global Outlook – By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Immunotherapy, Corticoster...

Lower Respiratory Tract Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Asthma, Chronic Obstructive Pulmonary Disease, Pneumonia, Tuberculosis, Bronchitis, Other Diseases), By Drug Class (Antibiotics,...

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report 2026 - Global Outlook – By Type (Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

How big is the Asthma Therapeutics Market?

The Asthma Therapeutics market was valued at $33.11 billion in 2025, increased to $35.73 billion in 2026, and is projected to reach $47.87 billion by 2030.

What is the Asthma Therapeutics market growth?

The global Asthma Therapeutics market is expected to grow at a CAGR of 7.6% from 2026 to 2035 to reach $47.87 billion by 2035.

Who are the key players in Asthma Therapeutics market?

Some Key Players in the Asthma Therapeutics market Include, Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V. .

What is the anticipated growth trend for the Asthma Therapeutics market?

Major trend in this market includes: Advancements In Anti Inflammatory Rescue Inhalers Improve Symptom Relief And Airway Inflammation Management In Asthma. For further insights on this market. request a sample here

Which region has the most growth potential in the Asthma Therapeutics market?

North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.